Navigation Links
Verenium Reports Financial Results for the Third Quarter 2010
Date:11/9/2010

tates and China;
  • Renewed and extended the Company's successful joint marketing agreement with Alfa Laval for Purifine® PLC for five years; and
  • Licensed a new lipase enzyme for use in the production of edible oil products to Bunge Oils, Inc.

  • Manufacturing

  • Hired Kevin Bracken as Vice President of Manufacturing to lead the optimization and expansion of manufacturing capabilities; and
  • Acquired control of additional fermentation capacity at Fermic, the Company's contract manufacturing facility in Mexico City.

  • Corporate/Financial:

  • Completed the sale of the Company's cellulosic biofuels business to BP, including facilities in Jennings, LA and San Diego, CA for net cash proceeds of $95.4 million;
  • Repurchased $21 million in principal amount of 8% and 5.5% Notes, eliminating all outstanding 8% Notes;
  • Appointed Alexander Fitzpatrick as Senior Vice President and General Counsel, further building out the senior management team;
  • Ended the quarter with unrestricted cash and cash equivalents totaling $89 million;
  • Increased total product revenue by 11% and 16% for the three and nine months ended September 30, 2010 respectively, when compared to the same periods in 2009;
  • Improved revenue mix from increasing sales of Company's newer enzymes including Fuelzyme, Xylathin, Veretase and Purifine; and
  • Increased product gross margin dollars by 17% and 20% for the three and nine months ended September 30, 2010 as compared to the same periods in 2009.

  • "The third quarter was an important quarter for Verenium in terms of demonstrating the growth potential of our enzyme products in all our industry areas," said James E. Levine, Executive Vice President and Chief Financial Officer.  "With the close of the BP transaction, we now have the financial flexibility to invest in the company and grow our enzymes business."

    Financial ResultsIn the commenta
    '/>"/>

    SOURCE Verenium Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related biology technology :

    1. Verenium to Present at Jefferies 10th Global Clean Technology Conference
    2. Verenium and Alfa Laval Announce Extension of Purifine® PLC Enzyme Agreement
    3. Verenium Announces Regulatory Approval for Purifine® PLC in China
    4. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
    5. Verenium Appoints Kevin Bracken Vice President of Manufacturing
    6. Verenium Announces Proposed Public Offering of Common Stock
    7. Verenium 1:12 Reverse Stock Split Takes Effect
    8. Verenium Announces Reverse Stock Split to Take Effect September 9
    9. BP and Verenium Announce Vercipia Biofuels to Advance the Commercialization of Cellulosic Ethanol
    10. Verenium Completes Amendment to 8% Senior Convertible Notes
    11. Verenium Announces Organizational Changes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/22/2014)... Md. (PRWEB) October 21, 2014 Shimadzu ... an LC/MS/MS data tool for the pain management and ... of data processing and review by allowing users to ... to clinicians. , QuantAnalytics allows analysts to filter ... This expedites data processing by eliminating the need to ...
    (Date:10/22/2014)... Currently offering a comprehensive portfolio ... Weighing, Rice Lake, and Ohaus, Pipette.com has added ... Sartorius CPA Semi-Micro Balance is ideal for lab ... user-friendly laboratory balance. , Sartorius is a global ... balances are well known for their high performance, ...
    (Date:10/22/2014)... According to new market research report "Cloud ... Deployment & Support), by Service Model (SaaS, PaaS, ... (Hybrid & Community)) - Global Forecast to 2019", ... Professional Services Market into various sub-segments with an ... identifies the drivers and restraints for this market ...
    (Date:10/22/2014)... YORK , Oct. 22, 2014 Nuvilex, ... Federation, approximately 400 million people worldwide are living with ... million people by 2030.  The global market for diabetes ... 2012 approximately 330,000 people worldwide died from pancreatic cancer.  ... death due to cancer in the United ...
    Breaking Biology Technology:Shimadzu Releases QuantAnalytics Open Access LCMS Software Package for Clinical Applications 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2
    ... Northwest,Biotherapeutics, Inc. (OTC Bulletin Board: NWBO; ... today that Lonza Group AG has,withdrawn all ... and other NWBT DCVax(R) products other than ... vaccine products infringed,certain gene expression technology patents ...
    ... offers substance abuse treatment for teens and adults, ... has announced the expansion of its treatment services to,include ... 12 - 17 as well,as adults, and the hospital ... health and dual diagnosis (substance abuse and,mental illness)., ...
    ... ALTO, Calif., Dec. 19 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... Barron, MD, FACC to its Board of Directors. Dr. ... Officer at Genentech,where he leads the Development organization, which ... Barron joined Genentech in 1996 as a clinical scientist ...
    Cached Biology Technology:Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 2Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 3Lonza Withdraws Majority of Claims in Patent Lawsuit Against Northwest Biotherapeutics 4Highlands Behavioral Health Hospital Unveils New Substance Abuse Detox Program 2Alexza Elects Dr. Hal V. Barron to Its Board of Directors 2Alexza Elects Dr. Hal V. Barron to Its Board of Directors 3
    (Date:10/16/2014)... constantly wages war on the human body. Battles ... stalemate. In pancreatic cancer, this stalemate—known as tumor ... aggressively malignant, a phenomena that is poorly understood. ... the laboratory of Salvatore Torquato, a Professor of ... conditions surrounding tumor dormancy and the switch to ...
    (Date:10/16/2014)... researchers have challenged conventional thinking on how the bowel ... mechanism for how bowel cancer starts. , The researchers ... and regenerating the ,crypts, that are a feature of ... involved in bowel cancer development, a controversial finding as ... , Using 3D imaging technologies, Dr Chin Wee Tan ...
    (Date:10/16/2014)... 16, 2014) – Post-menopausal women experienced improvements in ... levels or genital bleeding, after 12 weeks of ... fermented soy germ-based nutritional supplement previously shown to ... new peer-reviewed pilot study reported in a poster ... scientific meeting. , "These data documented improved ...
    Breaking Biology News(10 mins):Modeling tumor dormancy 2Cryptic clues drive new theory of bowel cancer development 2S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2
    ... By manipulating highly specific gene-regulating molecules called microRNAs, scientists at ... in singling out and repressing stem-like cells in mouse breast ... to cancer. If certain forms of breast cancer do ... believe to be the case, then it is critical to ...
    ... induce cells to form parallel tube-like structures that could one ... found that they can control the cells, development by growing ... the work was posted this month in an online issue ... day be transplanted into tissues such as the kidneys, liver, ...
    ... events that are critical to a healthy life, giving ... to think. But thats if the neurotransmitters are getting ... cells, neurons or other cells. Now a ... transcription factor that controls a neurotransmitter in the nematode ...
    Cached Biology News:CSHL scientists identify and repress breast cancer stem cells in mouse tissue 2CSHL scientists identify and repress breast cancer stem cells in mouse tissue 3MIT works toward engineered blood vessels 2Overexcited neurons not good for cell health 2Overexcited neurons not good for cell health 3
    ... Thermocycler provides high speed and excellent temperature ... a TGradient Thermocycler can be run without ... a silver block for 48 or 96 ... plates or in-situ applications are available. The ...
    General description: MaxiSorp TM surface is ideal for arraying molecules with mixed hydrophilic/hydrophobic domains such as proteins ID clarifier: Maxisorp(tm) with lid...
    ... tray. Ideal for staining westerns and includes ... multipurposes. Pour spouts in each corner facilitate ... may be used for identification. Lid is ... shakers for staining several gels simultaneously. Lid ...
    ID clarifier: non-treated with lid...
    Biology Products: